|
Pembrolizumab therapy for microsatellite instability high (MSI-H) colorectal cancer (CRC) and non-CRC. |
|
|
Leadership - Personal Genome Diagnostics |
Stock and Other Ownership Interests - PapGene, Inc.; Personal Genome Diagnostics |
Consulting or Advisory Role - Genentech; Merck; Personal Genome Diagnostics |
Speakers' Bureau - Cell Design Labs |
Research Funding - Merck (Inst) |
Patents, Royalties, Other Intellectual Property - PapGene, PGDx and other entities have licensed several patent applications from Johns Hopkins, where Dr. Diaz is an inventor. These relationships are subject to certain restrictions under Johns Hopkins University policy, and the terms of these arrangement |
Travel, Accommodations, Expenses - Merck |
|
|
Honoraria - Bristol-Myers Squibb; Genentech; Merck; Roche |
Consulting or Advisory Role - Amgen; Genentech; Novartis; Roche |
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Merck; Roche |
Research Funding - Merus (Inst) |
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bristol-Myers Squibb; Clovis Oncology; Merck |
Consulting or Advisory Role - Clovis Oncology |
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck |
|
|
Honoraria - Bristol-Myers Squibb; Lilly; Medison; Novartis; Roche |
Consulting or Advisory Role - Merck; Novartis |
|
|
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Roche |
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Roche |
Speakers' Bureau - Bristol-Myers Squibb; Merck; Novartis; Roche |
Research Funding - Bristol-Myers Squibb; Merck; Novartis; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Novartis; Roche |
|
|
Consulting or Advisory Role - Amgen; Bayer; Roche |
|
|
Honoraria - Amgen; Baxter; BAYER; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD Oncology; Novartis; Roche/Genentech; Sanofi; SERVIER; Xbiotech |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Roche/Genentech |
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche/Genentech |
|
|
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst) |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Roche |
|
|
No Relationships to Disclose |
|
|
Research Funding - Boehringer Ingelheim (Inst); GlaxoSmithKline K.K. (Inst) |
|
|
|
Stock and Other Ownership Interests - Merck |
|
|
|
Stock and Other Ownership Interests - Merck |
|
|
|
Stock and Other Ownership Interests - Merck |
|
|
|
Stock and Other Ownership Interests - Merck |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |